Vijay Kumar Prajapati

InstitutionCentral University of Rajasthan
AddressRajasthan
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in May 2020 and November 2020
    All Publications
    Bar chart showing 58 publications over 13 distinct years, with a maximum of 15 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Naik B, Mattaparthi VSK, Gupta N, Ojha R, Das P, Singh S, Prajapati VK, Prusty D. Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. J Biomol Struct Dyn. 2021 Jun 01; 1-25. PMID: 34062110.
      Citations:    Fields:    
    2. Rajput VS, Sharma R, Kumari A, Vyas N, Prajapati V, Grover A. Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins. J Biomol Struct Dyn. 2021 May 26; 1-18. PMID: 34038700.
      Citations: 1     Fields:    
    3. Kumar N, Admane N, Kumari A, Sood D, Grover S, Prajapati VK, Chandra R, Grover A. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework. Sci Rep. 2021 04 07; 11(1):7653. PMID: 33828130.
      Citations: 2     Fields:    Translation:HumansCells
    4. Sirohi PR, Gupta J, Somvanshi P, Prajapati VK, Grover A. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein. J Biomol Struct Dyn. 2020 Nov 27; 1-12. PMID: 33246394.
      Citations: 1     Fields:    
    5. Prakash O, Prajapati VK, Shahi AK, Khaitan T. Incidence of Maxillofacial Trauma Amid COVID-19: A Comparative Study. J Maxillofac Oral Surg. 2020 Nov 21; 1-6. PMID: 33250599.
      Citations: 1     
    6. Kumar BK, Sekhar KVGC, Ojha R, Prajapati VK, Pai A, Murugesan S. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J Biomol Struct Dyn. 2022 02; 40(3):1363-1386. PMID: 32981461.
      Citations: 3     Fields:    
    7. Naik B, Gupta N, Ojha R, Singh S, Prajapati VK, Prusty D. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int J Biol Macromol. 2020 Oct 01; 160:1-17. PMID: 32470577.
      Citations: 18     Fields:    Translation:HumansCells
    8. Ojha R, Gupta N, Naik B, Singh S, Verma VK, Prusty D, Prajapati VK. High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19. Eur J Pharm Sci. 2020 Aug 01; 151:105375. PMID: 32417398.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health